DK140801C - - Google Patents

Info

Publication number
DK140801C
DK140801C DK8375A DK8375A DK140801C DK 140801 C DK140801 C DK 140801C DK 8375 A DK8375 A DK 8375A DK 8375 A DK8375 A DK 8375A DK 140801 C DK140801 C DK 140801C
Authority
DK
Denmark
Application number
DK8375A
Other languages
Danish (da)
Other versions
DK8375A (en
DK140801B (en
Inventor
B A Hansen
F H Andresen
Original Assignee
Nordisk Insulin Laboratorium
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Insulin Laboratorium filed Critical Nordisk Insulin Laboratorium
Priority to DK8375AA priority Critical patent/DK140801B/en
Priority to ZA00760058A priority patent/ZA7658B/en
Priority to IN41/CAL/76A priority patent/IN143279B/en
Priority to GR49734A priority patent/GR58608B/en
Priority to FI760058A priority patent/FI66751C/en
Priority to NZ179733A priority patent/NZ179733A/en
Priority to CA243,587A priority patent/CA1094549A/en
Priority to DE2600971A priority patent/DE2600971C2/en
Priority to LU74175A priority patent/LU74175A1/xx
Priority to IT19221/76A priority patent/IT1054211B/en
Priority to IE62/76A priority patent/IE42395B1/en
Priority to SE7600284A priority patent/SE437219B/en
Priority to YU00083/76A priority patent/YU8376A/en
Priority to MX764822U priority patent/MX4052E/en
Priority to DD190805A priority patent/DD124379A5/xx
Priority to BR7600206A priority patent/BR7600206A/en
Priority to PT64696A priority patent/PT64696B/en
Priority to AT21376A priority patent/AT362492B/en
Priority to GB1309/76A priority patent/GB1524431A/en
Priority to NL7600338.A priority patent/NL166464C/en
Priority to FR7600854A priority patent/FR2297634A1/en
Priority to OA55703A priority patent/OA05209A/en
Priority to RO7684491A priority patent/RO71576A/en
Priority to PL1976186526A priority patent/PL99927B1/en
Priority to NO760118A priority patent/NO146698C/en
Priority to HU76NO198A priority patent/HU175142B/en
Priority to IL48845A priority patent/IL48845A/en
Priority to ES444558A priority patent/ES444558A1/en
Priority to CS76270A priority patent/CS208147B2/en
Priority to CH47076A priority patent/CH631625A5/en
Priority to AU10307/76A priority patent/AU492004B2/en
Priority to BE163542A priority patent/BE837600A/en
Priority to JP51003293A priority patent/JPS5946939B2/en
Priority to EG16/76A priority patent/EG11988A/en
Publication of DK8375A publication Critical patent/DK8375A/da
Priority to US05/858,916 priority patent/US4183849A/en
Priority to AR261924A priority patent/AR213088A1/en
Priority to KE2919A priority patent/KE2919A/en
Publication of DK140801B publication Critical patent/DK140801B/en
Priority to MY169/79A priority patent/MY7900169A/en
Application granted granted Critical
Publication of DK140801C publication Critical patent/DK140801C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • C07K14/625Extraction from natural sources
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK8375AA 1975-01-15 1975-01-15 Process for the preparation of a stable long-acting insulin preparation. DK140801B (en)

Priority Applications (38)

Application Number Priority Date Filing Date Title
DK8375AA DK140801B (en) 1975-01-15 1975-01-15 Process for the preparation of a stable long-acting insulin preparation.
ZA00760058A ZA7658B (en) 1975-01-15 1976-01-06 A therapeutic insulin preparation and a process for the production of a stable insulin preparation with protracted efect
GR49734A GR58608B (en) 1975-01-15 1976-01-07 Process for the production of a stable insulin preparation with protracted effect
IN41/CAL/76A IN143279B (en) 1975-01-15 1976-01-07
FI760058A FI66751C (en) 1975-01-15 1976-01-12 FOERFARANDE FOER FRAMSTAELLNING AV ETT STABILT INSULINPREPARATMED LAONGTIDSVERKAN
NZ179733A NZ179733A (en) 1975-01-15 1976-01-12 Stable insulin preparation
CA243,587A CA1094549A (en) 1975-01-15 1976-01-12 Therapeutic insulin preparation and a process for the production of a stable insulin preparation with protracted effect
LU74175A LU74175A1 (en) 1975-01-15 1976-01-13
IT19221/76A IT1054211B (en) 1975-01-15 1976-01-13 INSULIN PREPARATION AND PROCEEDINGS TO PRODUCE A STABLE PREPARATION D INSULIN WITH PROLONGED EFFECT
IE62/76A IE42395B1 (en) 1975-01-15 1976-01-13 Production of long acting insulin preparations
SE7600284A SE437219B (en) 1975-01-15 1976-01-13 PROCEDURE FOR PREPARING A STABLE INSULIN PREPARATION WITH PROTRAHERED EFFECT
DE2600971A DE2600971C2 (en) 1975-01-15 1976-01-13 Process for the preparation of bovine insulin complexes with sustained action and medicaments containing these complexes
NL7600338.A NL166464C (en) 1975-01-15 1976-01-14 PROCESS FOR PREPARING A STABLE INSULIN WITH LONG LASTING ACTION AND LOW ANTIGEN ACTIVITY.
DD190805A DD124379A5 (en) 1975-01-15 1976-01-14
BR7600206A BR7600206A (en) 1975-01-15 1976-01-14 PROCESS TO OBTAIN STABLE PREPARATION OF PROLONGED ACTION INSULIN, WELL AS COMPOSITION AND THERAPEUTIC PROCESS
PT64696A PT64696B (en) 1975-01-15 1976-01-14 PROCESS FOR PREPARING STABLE INSULIN COMPOSITIONS WITH PROLONGED ACTION
AT21376A AT362492B (en) 1975-01-15 1976-01-14 METHOD FOR PRODUCING A STABLE INSULIN PREPARATION WITH PERMANENT EFFECT
GB1309/76A GB1524431A (en) 1975-01-15 1976-01-14 Production of long acting insulin preparations
YU00083/76A YU8376A (en) 1975-01-15 1976-01-14 Process for producing a stable insulin preparation with retarded action
FR7600854A FR2297634A1 (en) 1975-01-15 1976-01-14 PROCESS FOR PRODUCING A STABLE THERAPEUTIC PREPARATION OF INSULIN AND PRODUCT OBTAINED
OA55703A OA05209A (en) 1975-01-15 1976-01-14 A process for producing a stable insulin preparation.
RO7684491A RO71576A (en) 1975-01-15 1976-01-14 METHOD OF OBTAINING STABLE PREPARATION OF INSULIN WITH PROLONGED EFFECT AND REDUCED ANTIGENICITY
PL1976186526A PL99927B1 (en) 1975-01-15 1976-01-14 METHOD OF MAKING A PERMANENT INSULIN PREPARATION WITH AN EXTENDED ACTIVITY
NO760118A NO146698C (en) 1975-01-15 1976-01-14 PROCEDURE FOR PREPARING A STABLE LONG-EFFECTIVE INSULIN PRODUCT.
MX764822U MX4052E (en) 1975-01-15 1976-01-14 IMPROVED PROCEDURE FOR THE PRODUCTION OF A STABLE INSULIN PREPARATION WITH PROLONGED EFFECT
IL48845A IL48845A (en) 1975-01-15 1976-01-15 Therapeutic insulin preparation and a process for the production of a stable insulin preparation with protracted effect
HU76NO198A HU175142B (en) 1975-01-15 1976-01-15 Process for producing insulin composition of prolonged activity, with weak antigenic effectivity
ES444558A ES444558A1 (en) 1975-01-15 1976-01-15 Production of long acting insulin preparations
CS76270A CS208147B2 (en) 1975-01-15 1976-01-15 Method of making the stabile low antigennous or the antigene of the plain insuline preparation of the protracted effect
CH47076A CH631625A5 (en) 1975-01-15 1976-01-15 Process for the production of a stable insulin preparation having a lasting action
AU10307/76A AU492004B2 (en) 1976-01-15 A therapeutic insulin preparation anda process forthe production ofa stable insulin preparation with protracted effect
BE163542A BE837600A (en) 1975-01-15 1976-01-15 COMPOSITION OF INSULIN AND PROCESS FOR PREPARATION
JP51003293A JPS5946939B2 (en) 1975-01-15 1976-01-16 Manufacturing method of insulin
EG16/76A EG11988A (en) 1975-01-15 1976-01-17 A process for producing a stable insulin preparation with protracted effect
US05/858,916 US4183849A (en) 1975-01-15 1977-12-08 Therapeutic insulin preparation and a process for the production of a stable insulin preparation with protracted effect
AR261924A AR213088A1 (en) 1975-01-15 1978-01-14 PROCEDURE FOR THE PRODUCTION OF A STABLE INSULIN PREPARATION WITH PROLONGED EFFECT
KE2919A KE2919A (en) 1975-01-15 1979-02-07 Production of long acting insulin preparations
MY169/79A MY7900169A (en) 1975-01-15 1979-12-30 Production of long acting insulin preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK8375AA DK140801B (en) 1975-01-15 1975-01-15 Process for the preparation of a stable long-acting insulin preparation.

Publications (3)

Publication Number Publication Date
DK8375A DK8375A (en) 1976-07-16
DK140801B DK140801B (en) 1979-11-19
DK140801C true DK140801C (en) 1980-04-21

Family

ID=8089535

Family Applications (1)

Application Number Title Priority Date Filing Date
DK8375AA DK140801B (en) 1975-01-15 1975-01-15 Process for the preparation of a stable long-acting insulin preparation.

Country Status (36)

Country Link
JP (1) JPS5946939B2 (en)
AR (1) AR213088A1 (en)
AT (1) AT362492B (en)
BE (1) BE837600A (en)
BR (1) BR7600206A (en)
CA (1) CA1094549A (en)
CH (1) CH631625A5 (en)
CS (1) CS208147B2 (en)
DD (1) DD124379A5 (en)
DE (1) DE2600971C2 (en)
DK (1) DK140801B (en)
EG (1) EG11988A (en)
ES (1) ES444558A1 (en)
FI (1) FI66751C (en)
FR (1) FR2297634A1 (en)
GB (1) GB1524431A (en)
GR (1) GR58608B (en)
HU (1) HU175142B (en)
IE (1) IE42395B1 (en)
IL (1) IL48845A (en)
IN (1) IN143279B (en)
IT (1) IT1054211B (en)
KE (1) KE2919A (en)
LU (1) LU74175A1 (en)
MX (1) MX4052E (en)
MY (1) MY7900169A (en)
NL (1) NL166464C (en)
NO (1) NO146698C (en)
NZ (1) NZ179733A (en)
OA (1) OA05209A (en)
PL (1) PL99927B1 (en)
PT (1) PT64696B (en)
RO (1) RO71576A (en)
SE (1) SE437219B (en)
YU (1) YU8376A (en)
ZA (1) ZA7658B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK374579A (en) * 1979-09-07 1981-03-08 Nordisk Insulinlab PROCEDURE FOR THE PREPARATION OF AN INJUCABLE INSULIN PREPARATION
US4459226A (en) * 1982-02-26 1984-07-10 Eli Lilly And Company Process for recovering insulin
US4801575A (en) * 1986-07-30 1989-01-31 The Regents Of The University Of California Chimeric peptides for neuropeptide delivery through the blood-brain barrier
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
AU609769B2 (en) * 1987-02-10 1991-05-09 Drug Delivery Systems Inc. Electrolytic transdermal delivery of proteins
US5447728A (en) 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US5643957A (en) 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2414560B1 (en) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Method for coating a surface of a component
JP5763053B2 (en) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Adapter, inhaler and atomizer
JP5658268B2 (en) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
CN102686260B (en) 2009-11-25 2014-10-01 贝林格尔.英格海姆国际有限公司 Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5874724B2 (en) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
WO2012130757A1 (en) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
JP6643231B2 (en) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
PL2835146T3 (en) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizer
US10716907B2 (en) 2014-05-07 2020-07-21 Boehringer Ingelheim International Gmbh Nebulizer
ES2954961T3 (en) 2014-05-07 2023-11-27 Boehringer Ingelheim Int Unit, nebulizer and method
PL3139984T3 (en) 2014-05-07 2021-11-08 Boehringer Ingelheim International Gmbh Nebulizer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1285023A (en) * 1968-08-09 1972-08-09 Novo Terapeutisk Labor As Improvements in or relating to injectable insulin preparations
US3758683A (en) * 1971-04-30 1973-09-11 R Jackson Insulin product

Also Published As

Publication number Publication date
AT362492B (en) 1981-05-25
PT64696A (en) 1976-02-01
NO146698B (en) 1982-08-16
NL166464B (en) 1981-03-16
CH631625A5 (en) 1982-08-31
ZA7658B (en) 1976-12-29
ATA21376A (en) 1980-10-15
FI66751B (en) 1984-08-31
DD124379A5 (en) 1977-02-16
MY7900169A (en) 1979-12-31
FI66751C (en) 1984-12-10
BE837600A (en) 1976-07-15
NZ179733A (en) 1978-04-28
AR213088A1 (en) 1978-12-15
BR7600206A (en) 1976-08-31
YU8376A (en) 1982-06-30
GB1524431A (en) 1978-09-13
FI760058A (en) 1976-07-16
DE2600971C2 (en) 1985-12-12
DK8375A (en) 1976-07-16
MX4052E (en) 1981-11-24
CA1094549A (en) 1981-01-27
KE2919A (en) 1979-03-30
LU74175A1 (en) 1977-03-18
NL166464C (en) 1981-08-17
RO71576A (en) 1980-12-30
IT1054211B (en) 1981-11-10
DK140801B (en) 1979-11-19
IL48845A0 (en) 1976-03-31
JPS51125299A (en) 1976-11-01
GR58608B (en) 1977-11-10
HU175142B (en) 1980-05-28
NO146698C (en) 1982-11-24
CS208147B2 (en) 1981-08-31
DE2600971A1 (en) 1976-07-22
IE42395L (en) 1976-07-15
PT64696B (en) 1977-08-10
NO760118L (en) 1976-07-16
JPS5946939B2 (en) 1984-11-15
IN143279B (en) 1977-10-29
PL99927B1 (en) 1978-08-31
AU1030776A (en) 1977-07-21
IE42395B1 (en) 1980-07-30
SE437219B (en) 1985-02-18
FR2297634B1 (en) 1979-03-30
FR2297634A1 (en) 1976-08-13
SE7600284L (en) 1976-07-16
OA05209A (en) 1981-02-28
IL48845A (en) 1981-06-29
ES444558A1 (en) 1977-05-16
EG11988A (en) 1978-06-30
NL7600338A (en) 1976-07-19

Similar Documents

Publication Publication Date Title
DK140801C (en)
JPS52600U (en)
JPS5711356Y2 (en)
JPS5513572B2 (en)
JPS5633903B2 (en)
JPS5630709Y2 (en)
JPS56492Y2 (en)
JPS5540712Y2 (en)
JPS5263304U (en)
JPS5273903U (en)
JPS5260736U (en)
CH472175A4 (en)
BG22119A1 (en)
BG22691A1 (en)
BG22101A1 (en)
BG22947A1 (en)
BG22960A1 (en)
CH601610A5 (en)
CH598533A5 (en)
CH575173A5 (en)
CH579725A5 (en)
BG22012A1 (en)
CH581412A5 (en)
CH598569A5 (en)
BG21347A1 (en)

Legal Events

Date Code Title Description
PBP Patent lapsed